全文获取类型
收费全文 | 9649篇 |
免费 | 408篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 151篇 |
儿科学 | 227篇 |
妇产科学 | 132篇 |
基础医学 | 1306篇 |
口腔科学 | 126篇 |
临床医学 | 434篇 |
内科学 | 2801篇 |
皮肤病学 | 224篇 |
神经病学 | 680篇 |
特种医学 | 404篇 |
外科学 | 1432篇 |
综合类 | 35篇 |
一般理论 | 4篇 |
预防医学 | 211篇 |
眼科学 | 241篇 |
药学 | 662篇 |
中国医学 | 24篇 |
肿瘤学 | 1064篇 |
出版年
2023年 | 52篇 |
2022年 | 86篇 |
2021年 | 147篇 |
2020年 | 80篇 |
2019年 | 102篇 |
2018年 | 148篇 |
2017年 | 124篇 |
2016年 | 202篇 |
2015年 | 199篇 |
2014年 | 254篇 |
2013年 | 348篇 |
2012年 | 544篇 |
2011年 | 594篇 |
2010年 | 359篇 |
2009年 | 303篇 |
2008年 | 575篇 |
2007年 | 630篇 |
2006年 | 645篇 |
2005年 | 636篇 |
2004年 | 612篇 |
2003年 | 661篇 |
2002年 | 671篇 |
2001年 | 192篇 |
2000年 | 156篇 |
1999年 | 181篇 |
1998年 | 176篇 |
1997年 | 121篇 |
1996年 | 99篇 |
1995年 | 89篇 |
1994年 | 82篇 |
1993年 | 99篇 |
1992年 | 120篇 |
1991年 | 103篇 |
1990年 | 81篇 |
1989年 | 95篇 |
1988年 | 89篇 |
1987年 | 63篇 |
1986年 | 69篇 |
1985年 | 56篇 |
1984年 | 36篇 |
1983年 | 40篇 |
1982年 | 31篇 |
1981年 | 34篇 |
1980年 | 19篇 |
1979年 | 30篇 |
1978年 | 24篇 |
1977年 | 18篇 |
1976年 | 11篇 |
1970年 | 8篇 |
1969年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Does Hyperthermia Induce Peritoneal Damage in Continuous Hyperthermic Peritoneal Perfusion? 总被引:3,自引:0,他引:3
Shido A Ohmura S Yamamoto K Kobayashi T Fujimura T Yonemura Y 《World journal of surgery》2000,24(5):507-511
To investigate the mechanisms of the peritoneal damage induced by continuous hyperthermic peritoneal perfusion (CHPP), protein
and fluid loss during and after CHPP and continuous normothermic peritoneal perfusion (CNPP) was studied. Sixteen patients
with advanced gastric cancer underwent peritoneal perfusion therapy with saline solution containing 150 to 300 mg cisplatin
and 30 to 60 mg mitomycin C for 60 minutes. The temperature in Douglas' pouch was maintained at 42.0°C in the CHPP group (n= 9) and 37.0°C in the CNPP group (n= 7) during perfusion. No statistical differences were found in patients' characteristics between the groups except the maximum
temperature in Douglas' pouch during perfusion (41.6°± 0.4°C and 37.6°± 0.4°C in CHPP and CNPP groups, respectively, p < 0.05). The amount of protein lost into the perfusate was 0.35 ± 0.22 g/kg body weight in the CHPP group and 0.37 ± 0.19
g/kg in the CNPP group, showing no significant difference. On the day of surgery, there was no significant difference in the
amount of protein and fluid lost through the abdominal drains between the CHPP group (27.9 ± 24.6 mg/kg/hr and 0.94 ± 0.63
ml/kg/hr, respectively) and the CNPP group (25.9 ± 8.6 mg/kg/hr and 1.03 ± 0.31 ml/kg/hr, respectively). We could not find
any significant differences in postoperative protein and fluid loss between the groups on the following 3 days either. We
conclude that the peritoneal damage by CHPP is not caused by the hyperthermia but by the peritoneal perfusion with saline
solution containing anticancer drugs. 相似文献
102.
(-)-Verbenone, a monoterpene bicyclic ketone, is a component of the essential oil from rosemary species such as Rosmarinus officinalis L., Verbena triphylla, and Eucalyptus globulus and is used for an herb tea, a spice, and a perfume. In this study, (-)-verbenone was found to be converted to 10-hydroxyverbenone by rat and human liver microsomal cytochrome p450 (p450) enzymes. The product formation was determined by high-performance liquid chromatography with UV detection at 251 nm. There was a good correlation between activities of coumarin 7-hydroxylation and (-)-verbenone 10-hydroxylation catalyzed by liver microsomes of 16 human samples, indicating that CYP2A6 is a principal enzyme in (-)-verbenone 10-hydroxylation in humans. Human recombinant CYP2A6 and CYP2B6 catalyzed (-)verbenone 10-hydroxylation at Vmax values of 15 and 21 nmol/min/nmol p450 with apparent Km values of 16 and 91 microM, respectively. In contrast, rat CYP2A1 and 2A2 did not catalyze (-)-verbenone 10-hydroxylation at all, suggesting that there were species-related differences in the catalytic properties of human and rat CYP2A enzymes in the metabolism of (-)-verbenone. In the rat, recombinant CYP2C11, CYP2B1, and CYP3A2 catalyzed (-)-verbenone 10-hydroxylation with Vmax and Km ratios (ml/min/nmol p450) of 0.73, 0.20, and 0.03, respectively. Male-specific CYP2C11 was a major enzyme in (-)-verbenone 10-hydroxylation by untreated rat livers, and CYP2B1 catalyzed this reaction in liver microsomes of phenobarbital-treated rats. Rat CYP2C12, a female-specific enzyme, did not catalyze (-)verbenone 10-hydroxylation. These results suggest that human CYP2A6 and rat CYP2C11 are the major catalysts in the metabolism of (-)-verbenone by liver microsomes and that there are species-related differences in human and rat CYP2A enzymes and sex-related differences in male and female rats in the metabolism of (-)-verbenone. 相似文献
103.
104.
The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. 总被引:3,自引:0,他引:3
PURPOSE: The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue is not clearly known. Changes in dihydrotestosterone levels in the prostatic tissue during androgen deprivation therapy in the same patients have not been reported. We analyzed dihydrotestosterone levels in prostatic tissue before and after androgen deprivation therapy. EXPERIMENTAL DESIGN: A total of 103 patients who were suspected of having prostate cancer underwent prostatic biopsy. Sixty-nine patients were diagnosed as having prostate cancer whereas the remaining 34 were negative. Serum samples were collected before biopsy or prostatectomy. Dihydrotestosterone levels in prostatic tissue and serum were analyzed using liquid chromatography/electrospray ionization-mass spectrometry after polar derivatization. In 30 of the patients with prostate cancer, dihydrotestosterone levels in prostatic tissue were determined by performing rebiopsy or with prostate tissues excised after 6 months on androgen deprivation therapy with castration and flutamide. RESULTS: Dihydrotestosterone levels in prostate tissue after androgen deprivation therapy remained at approximately 25% of the amount measured before androgen deprivation therapy. Dihydrotestosterone levels in serum decreased to approximately 7.5% after androgen deprivation therapy. The level of dihydrotestosterone in prostatic tissue before androgen deprivation therapy was not correlated with the serum level of testosterone. Serum levels of adrenal androgens were reduced to approximately 60% after androgen deprivation therapy. CONCLUSIONS: The source of dihydrotestosterone in prostatic tissue after androgen deprivation therapy involves intracrine production within the prostate, converting adrenal androgens to dihydrotestosterone. Dihydrotestosterone still remaining in prostate tissue after androgen deprivation therapy may require new therapies such as treatment with a combination of 5alpha-reductase inhibitors and antiandrogens, as well as castration. 相似文献
105.
Inaba H Miyaji K Kaneko Y Ohtsuka T Ezure M Tambara K Takamoto S Omata S 《Artificial organs》2000,24(10):808-815
In clinical settings, no method has been established to examine the fatigue of a latissimus dorsi muscle (LDM) preconditioned for cardiomyoplasty. We examined the feasibility of measuring muscle stiffness (tactile stiffness) to evaluate muscle fatigue in situ using our tactile sensor. We stimulated canine LDM with burst pacing and monitored both stiffness and tension to determine their relationship. In both dissected LDM and LDM in situ, the decrements of these parameters during burst pacing were compared between preconditioned and unconditioned LDM. In measurement in situ, the sensor probe was placed on the LDM through a small incision. Strong statistical correlation was shown between stiffness and tension (r = 0.935). In decrements of stiffness in situ, there were statistically significant differences between preconditioned and unconditioned LDM. Our tactile sensor system can provide an efficient method for evaluating fatigue of muscles in situ without measuring muscle tension. 相似文献
106.
107.
108.
Somatic Mutations of the PTEN/MMAC1 Gene in Fifteen Japanese Endometrial Cancers: Evidence for Inactivation of Both Alleles 总被引:3,自引:1,他引:3
Keisuke Kurose Koichi Bando Koichi Fukino Yuichi Sugisaki Tsutomu Araki Mitsuru Emi 《Cancer science》1998,89(8):842-848
Loss of heterozygosity (LOH) of chromosome 10q is observed in approximately 40% of endometrial cancers. Mutations in PTEN/MMAC1 , a gene recently isolated from the 10q23 region, are responsible for two dominantly inherited neoplastic syndromes, Cowden disease and Bannayan-Zonana syndrome. Somatic mutations of this gene have also been detected in sporadic cancers of the brain, prostate and breast. To investigate the potential role of this putative tumor suppressor gene in endometrial carcinogenesis as well, we examined 46 primary endometrial cancers for LOH at the 10q23 region, and for mutations in the entire coding region and exon-intron boundaries of the PTEN/MMAC1 gene. LOH was identified in half of the 38 informative cases, and subtle somatic mutations were detected in 15 tumors (33%). Our results suggest that of the genes studied so far in endometrial carcinomas, PTEN/MMAC1 is the most commonly mutated one, and that inactivation of both copies by allelic loss and/or mutation, a pattern that defines genes as "tumor suppressors,'contributes to tumorigenesis in endometrial cancers. 相似文献
109.
Atsushi Yoshida Takashi Sugiyama Tsutomu Tabata Toshiharu Okugawa Norimasa Sagawa 《The Ultrasound Review of Obstetrics & Gynecology》2006,6(3):109-114
The usefulness of the vascular ultrasound in the field of obstetrics is now well recognized. Intima-media thickness (IMT) and elastic property of the common carotid artery are affected by pregnancy and vary with complications. Flow-mediated vasodilation (FMD) of the brachial artery reflects the vascular endothelial function and is reported to be useful in the management of complicated pregnancy, especially pre-eclampsia. For the screening of deep vein thrombosis of the lower extremities in the perinatal period, compression ultrasonography (CUS) is useful. 相似文献
110.
Yonemori K Katsumata N Kaneko M Uno H Matsumoto K Kouno T Shimizu C Ando M Takeuchi M Fujiwara Y 《Breast cancer research and treatment》2007,103(3):313-318
Summary
Purpose: The aim of this study was to identify the predictors of the response to doxorubicin plus cyclophosphamide in patients with
recurrent breast cancer (RBC) previously treated with anthracycline-containing regimens in a neoadjuvant or adjuvant setting.
Method: Between December 1993 and October 2005, 664 patients had received combined doxorubicin plus cyclophosphamide chemotherapy
(doxorubicin, 40 mg/m2, iv on day 1; cyclophosphamide, 500 mg/m2, iv on day 1, every 21 days) for RBC at our institution. In this study, we retrospectively analyzed the efficacy of doxorubicin
plus cyclophosphamide in 99 of these 664 RBC patients who had also previously been administered an anthracycline-based chemotherapy
in a neoadjuvant or adjuvant setting.
Results: The median cumulative dose of the previously administered anthracycline was 156 mg/m2. The median disease-free interval (DFI) and median anthracycline-free interval were 33.8 and 43.7 months, respectively. The
overall response rate to doxorubicin plus cyclophosphamide therapy was 38.4% (95% CI; range, 28.8–48.0%). The median time
to progression and overall survival were 6.2 and 17.5 months, respectively. The results of a multivariate logistic regression
analysis revealed a significant association of the response to doxorubicin plus cyclophosphamide therapy with the DFI (P = 0.02); human epidermal receptor type 2 (HER2) status also tended to affect the response rate, however the association was
not statistically significant (P = 0.06).
Conclusion: DFI and HER2 status may be associated with the response to repeat utilization of anthracycline-containing regimens in RBC
patients also treated previously with anthracycline-containing chemotherapeutic regimens in a neoadjuvant or adjuvant setting. 相似文献